The Fight Malaria Blog
  • About
  • Malaria Minute
  • Interviews
  • Hot Topics
  • Quiz
  • Contact

Malaria Minute

The Latest Malaria News, in 60 Seconds.

In September 2021, the Malaria Minute was rebranded the Johns Hopkins Malaria Minute.
Listen Now or Read the Announcement

Malaria Minute

‘Origami’ Malaria Test Proves 98% Accurate

A paper-based microfluidic malaria test proves 98% accurate, Italian researchers begin a CRISPR gene drive experiment by sterilising female mosquitos and Lauren Carruthers shares her malaria poem.

By Thomas Locke, 4 years22nd February 2019 ago
Malaria Minute

Geneva Meeting Strengthens Global Malaria Communications

The SCPC committee meet in Switzerland to discuss global malaria communications, the Anopheline mosquito may have transmitted malaria before human existence and a Chinese scientist claims that the Plasmodium parasite can cure cancer.

By Thomas Locke, 4 years15th February 2019 ago
Malaria Minute

DNA from Single Mosquito Used to Produce Genome Assembly

WHO fails to recognise ‘socio-cultural’ context of communities in vaccine trials, scientists make genome assembly from DNA of single mosquito and researchers find that a parasite’s genome organisation correlates with its virulence.

By Thomas Locke, 4 years8th February 2019 ago
Malaria Minute

Fever Tree Commits £1 Million to Fight Malaria

Fever Tree increases malaria funding by £1 million, the economic impact of fake antimalarials is quantified and the BBC shares the story of Zanzibar’s malaria control program.

By Thomas Locke, 4 years1st February 2019 ago
Malaria Minute

Malaria Vaccine Promises ‘Lifetime Immunity’

Novel malaria vaccine offers ‘lifetime immunity’, drones offer a solution to Africa’s lack of satellite imagery, the UK’s funding towards global health skyrockets in recent years and to halt malaria, more focus is needed on human behaviour.

By Thomas Locke, 4 years25th January 2019 ago
Malaria Minute

The Global Fund Seeks $14 Billion to Fight AIDS, Tuberculosis and Malaria

The Global Fund seeks $14 billion to fund its disease work, a vaccine against fatal pregnancy malaria shows promising results and the Anopheles Stephensi mosquito is found in Ethiopia.

By Thomas Locke, 4 years18th January 2019 ago
Malaria Minute

ACT Drug Resistance Reported in India

Indian researchers report cases of artemisinin resistance, a Burundian entrepreneur develops mosquito-repellent cosmetics and ineffective and untreated bed nets stall progress against malaria in Uganda.

By Thomas Locke, 4 years11th January 2019 ago
Malaria Minute

Tafenoquine Declared ‘Safe and Effective’ in Oxford Study

The University of Florida develops ‘spit test’ for malaria, a new study shows that Tafenoquine is ‘safe and effective’ for the prevention of malaria and the threat of antimalarial drug resistance.

By Thomas Locke, 4 years4th January 2019 ago
Malaria Minute

Japanese Scientists Identify Virus That Can Destroy Malaria Parasite

The fight against the world’s deadliest diseases can be won with sustained investment, malaria is over-diagnosed in Nigeria and scientists in Japan find that baculovirus can destroy liver-stage parasites.

By Thomas Locke, 4 years28th December 2018 ago
Malaria Minute

Ugandan AI Lab Develops Malaria Detection App

Uganda’s first AI lab develops a mobile app for the detection of malaria, infants born with low birth weight are twice as likely to have malaria and Ghanaian farmers are unable to harvest 60% of their crops every year due to the disease.

By Thomas Locke, 4 years21st December 2018 ago

Posts navigation

Previous 1 … 10 11 12 … 17 Next
About Malaria Minute

The Malaria Minute podcast brings you global malaria news in 60 seconds. Updated weekly.

Available on MalariaWorld:


 

 

We assimilate malaria research and communicate key findings in podcast form.

Along the way, we interview scientists and decision-makers from around the world.

Learn More


News

Contact

Uptime Status

Distilling the science of malaria

We assimilate malaria research and communicate key findings in podcast form.

Along the way, we interview scientists and decision-makers from around the world.

About

News

Contact

Legal

Terms of Use

Privacy Policy

Cookie Policy

Change Cookie Preferences

 

Uptime Status

Creative Commons Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Hestia | Developed by ThemeIsle